| Financial Year |
March 31 2023 |
| Monetary Funds |
2,965,997,927.58 |
| Held-for-trading Financial Assets |
682,017,847.80 |
| Notes Receivable |
203,188,201.89 |
| Accounts Receivable |
1,247,111,902.19 |
| Advances to Suppliers |
6,789,269.67 |
| Other Receivables |
34,754,256.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
721,780,105.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,226,451.09 |
| Total Current Assets |
6,006,865,761.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
404,252,992.95 |
| Investment Properties |
-- |
| Fixed Assetes |
3,674,498,452.40 |
| Under-construction Projects |
981,632,971.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
268,855,899.28 |
| R&D expenses |
-- |
| Goodwill |
476,017.08 |
| Long-Term Deferred and Prepaid Expenses |
77,618,513.41 |
| Deferred Income Tax Assets |
54,935,572.01 |
| Other Non-Current Assets |
51,179,292.33 |
| Sub-Total of Non-Current Assets |
5,563,085,540.30 |
| Total Assets |
11,569,951,301.82 |
| Short-Term Loans |
145,391,690.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
469,812,177.50 |
| Accounts Payable |
1,234,644,961.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
75,506,198.16 |
| Taxes Payable |
40,859,702.35 |
| Interest Payable |
-- |
| Dividend Payable |
9,073.60 |
| Other payables |
206,893,374.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,552,434.72 |
| Other Current Liabilities |
4,043,477.30 |
| Sub-Total of Current Liabilities |
2,203,486,459.48 |
| Long-term Loans |
236,201,137.52 |
| Bonds Payable |
1,374,548,965.40 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
10,261,636.44 |
| Deferred Income Tax Liabilities |
276,457.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,746,742,570.98 |
| Total Liabilities |
3,950,229,030.46 |
| Paid-In Capital(Or Share Stock) |
1,092,320,877.00 |
| Capital Surplus |
3,138,662,726.57 |
| Surplus Reserve |
253,102,755.76 |
| LESS:Treasury Stock |
79,895,000.00 |
| Undistributed Profits |
2,603,913,802.55 |
| Minority Stockholder's Interest |
464,755,644.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,154,966,626.99 |
| Owner's Equity（Stockholder's Equity） |
7,619,722,271.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,569,951,301.82 |
